Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6103734 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL14296858 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL13298755 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL14543427 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL6102466 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL6101532 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL13298726 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL21938542 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL21641566 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL10439398 | 0.85 | CA2 (0.38) | CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12083140-B2 | Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative | FUTURE MEDICINE CO., LTD. (KR) | 2024-09-10 | — | — | US | disclosed |
| EP-3603647-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING GLAUCOMA, CONTAINING ADENOSINE DERIVATIVE | FUTURE MEDICINE CO LTD (KR) | 2024-08-21 | — | — | EP | disclosed |
| US-20210386771-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING GLAUCOMA, CONTAINING ADENOSINE DERIVATIVE | FUTURE MEDICINE CO., LTD. (KR) | 2021-12-16 | — | — | US | disclosed |
| US-11185556-B2 | Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative | FUTURE MEDICINE CO., LTD. (KR) | 2021-11-30 | — | — | US | disclosed |
| EP-3603647-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING GLAUCOMA, CONTAINING ADENOSINE DERIVATIVE | Future Medicine Co., Ltd. (KR) | 2020-02-05 | — | — | EP | disclosed |
| US-9018371-B2 | Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient | FM THERAPEUTICS CO., LTD. (KR) | 2015-04-28 | — | — | US | disclosed |
| EP-2142549-B1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FM THERAPEUTICS CO LTD (KR) | 2013-07-10 | — | — | EP | disclosed |
| US-20100137577-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | FUTURE MEDICINE CO., LTD. (KR) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11185556-B2 | Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative | ADORA1, ADORA2A, PDE3A | CA2 161/4885CA1 3113/4885CA9 578/4885 |
| US-12083140-B2 | Pharmaceutical composition for preventing and treating glaucoma, containing adenosine derivative | ADORA1, ADORA2A, ADORA3 | CA2 145/4885CA1 3088/4885CA9 508/4885 |
| US-20210386771-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING GLAUCOMA, CONTAINING ADENOSINE DERIVATIVE | ADORA1, ADORA2A, ADORA3 | CA2 145/4885CA1 3088/4885CA9 508/4885 |
| US-20100137577-A1 | ADENOSINE DERIVATIVES, METHOD FOR THE SYNTHESIS THEREOF, AND THE PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE INFLAMMATORY DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT | ADORA3, ADORA2A, ADORA1 | CA2 3844/4885CA1 4342/4885CA9 4061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.